Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Rehberg

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Spine|May 17, 2023
Duration of Surgery and Intraoperative Blood Pressure Management Are Modifiable Risk Factors for Postoperative Neurocognitive Disorders After Spine Surgery: Results of the Prospective CONFESS StudyJonas Müller, Stephan Nowak, Martin Weidemeier, et al.
Intensive Care Medicine|September 19, 2024
Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP)Sebastian Rehberg, Sandra Frank, Vladimír Černý, et al.
Cardiovascular Drugs and Therapy|August 10, 2013
Renal effects of levosimendan: a consensus reportMehmet B Yilmaz, Elena Grossini, José C Silva Cardoso, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Spine|May 17, 2023
Duration of Surgery and Intraoperative Blood Pressure Management Are Modifiable Risk Factors for Postoperative Neurocognitive Disorders After Spine Surgery: Results of the Prospective CONFESS StudyJonas Müller, Stephan Nowak, Martin Weidemeier, et al.
Intensive Care Medicine|September 19, 2024
Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP)Sebastian Rehberg, Sandra Frank, Vladimír Černý, et al.
Cardiovascular Drugs and Therapy|August 10, 2013
Renal effects of levosimendan: a consensus reportMehmet B Yilmaz, Elena Grossini, José C Silva Cardoso, et al.
Pageof 13